Shanghai Rongtai Health Technology Corporation Limited (SHA:603579)
China · Delayed Price · Currency is CNY 24.95
+0.24 (0.97%)
At close: Feb 6, 2026
SHA:603579 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 160.26 | 191.95 | 202.71 | 164.23 | 236.34 | 193 |
Depreciation & Amortization | 55.37 | 55.37 | 59.96 | 58.92 | 62.78 | 47.14 |
Other Amortization | 5.01 | 5.01 | 9.78 | 14.69 | 6.18 | 5.89 |
Loss (Gain) From Sale of Assets | -0.7 | -0.7 | 0.95 | -0.15 | -1.31 | -2.88 |
Asset Writedown & Restructuring Costs | 1.21 | 1.21 | 1.29 | 0.01 | 1.7 | 0.14 |
Loss (Gain) From Sale of Investments | -37.54 | -37.54 | -20.5 | -34.6 | -99.5 | -24.82 |
Provision & Write-off of Bad Debts | 1.13 | 1.13 | -1.3 | 30.49 | 56.6 | 29.32 |
Other Operating Activities | 132.1 | 11.39 | 33.63 | 14.58 | 44.59 | 33.82 |
Change in Accounts Receivable | -10.43 | -10.43 | -114.93 | 115.61 | -115.66 | 135.6 |
Change in Inventory | -10.84 | -10.84 | 55.03 | 71.05 | -33.3 | -11.94 |
Change in Accounts Payable | -43.23 | -43.23 | 118.5 | -198.77 | 178.44 | -117.94 |
Change in Other Net Operating Assets | 1.95 | 1.95 | 10.62 | 7.44 | -11.09 | -0.22 |
Operating Cash Flow | 257.16 | 168.14 | 344.29 | 236.79 | 337.92 | 275.59 |
Operating Cash Flow Growth | 41.90% | -51.16% | 45.40% | -29.93% | 22.61% | -38.27% |
Capital Expenditures | -151.28 | -151.08 | -89.61 | -100.65 | -141.46 | -190.13 |
Sale of Property, Plant & Equipment | 4.37 | 1.96 | 2.81 | 4.38 | 7.7 | 5.16 |
Divestitures | - | - | - | - | -8.16 | - |
Investment in Securities | -948.24 | -1,026 | 207.57 | -128.78 | 88.61 | -412.36 |
Other Investing Activities | 797.27 | 2.49 | 0.19 | - | -11.99 | - |
Investing Cash Flow | -297.88 | -1,173 | 120.96 | -225.04 | -65.3 | -597.34 |
Short-Term Debt Issued | - | - | - | 543.76 | 114.77 | 880.32 |
Long-Term Debt Issued | - | 425.79 | 149.13 | - | - | - |
Total Debt Issued | 344.42 | 425.79 | 149.13 | 543.76 | 114.77 | 880.32 |
Short-Term Debt Repaid | - | - | - | -249.5 | - | -316.07 |
Long-Term Debt Repaid | - | -129.13 | -429.02 | -1.12 | -4.28 | - |
Total Debt Repaid | -569.17 | -129.13 | -429.02 | -250.62 | -4.28 | -316.07 |
Net Debt Issued (Repaid) | -224.75 | 296.66 | -279.89 | 293.14 | 110.49 | 564.25 |
Issuance of Common Stock | 22.97 | 22.97 | - | - | 80.42 | - |
Repurchase of Common Stock | - | - | -50.01 | - | -100.05 | - |
Common Dividends Paid | -125.71 | -199.82 | -78.06 | -103.59 | -72.25 | -206.94 |
Other Financing Activities | -21.13 | 0.76 | -18.21 | -1.95 | -44.82 | 0.5 |
Financing Cash Flow | -348.62 | 120.57 | -426.17 | 187.59 | -26.22 | 357.81 |
Foreign Exchange Rate Adjustments | 5.96 | 3.7 | 10 | 21.19 | -17.2 | -29.26 |
Net Cash Flow | -383.37 | -880.09 | 49.09 | 220.53 | 229.19 | 6.81 |
Free Cash Flow | 105.88 | 17.06 | 254.69 | 136.14 | 196.45 | 85.46 |
Free Cash Flow Growth | 76.62% | -93.30% | 87.08% | -30.70% | 129.87% | -70.02% |
Free Cash Flow Margin | 6.70% | 1.07% | 13.73% | 6.79% | 7.52% | 4.23% |
Free Cash Flow Per Share | 0.58 | 0.09 | 1.47 | 0.78 | 1.08 | 0.48 |
Cash Income Tax Paid | 10.7 | -30.42 | 27.21 | -49.67 | -72.46 | -42.02 |
Levered Free Cash Flow | -171.94 | -1.98 | 92.24 | -25.02 | 35.84 | 14.04 |
Unlevered Free Cash Flow | -157.33 | 1.71 | 109.37 | -7.03 | 53.8 | 18.31 |
Change in Working Capital | -59.67 | -59.67 | 57.79 | -11.38 | 30.54 | -6.02 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.